CC2D1A
Basic information
Region (hg38): 19:13906201-13930879
Links
Phenotypes
GenCC
Source:
- intellectual disability, autosomal recessive 3 (Definitive), mode of inheritance: AR
- intellectual disability, autosomal recessive 3 (Moderate), mode of inheritance: AR
- autosomal recessive non-syndromic intellectual disability (Supportive), mode of inheritance: AR
- complex neurodevelopmental disorder (Definitive), mode of inheritance: AR
- intellectual disability, autosomal recessive 3 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Intellectual developmental disorder, autosomal recessive 3 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 16033914; 17149387 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (471 variants)
- Inborn_genetic_diseases (264 variants)
- Intellectual_disability,_autosomal_recessive_3 (66 variants)
- not_specified (57 variants)
- CC2D1A-related_disorder (33 variants)
- Intellectual_disability (5 variants)
- Ciliopathy (2 variants)
- Smith-Magenis_Syndrome-like (2 variants)
- Cerebral_palsy (1 variants)
- Autosomal_recessive_non-syndromic_intellectual_disability (1 variants)
- Visual_impairment (1 variants)
- Global_developmental_delay (1 variants)
- Premature_ovarian_failure_19 (1 variants)
- Autism (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CC2D1A gene is commonly pathogenic or not. These statistics are base on transcript: NM_000017721.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 170 | 176 | ||||
| missense | 197 | 60 | 260 | |||
| nonsense | 12 | |||||
| start loss | 0 | |||||
| frameshift | 16 | 23 | ||||
| splice donor/acceptor (+/-2bp) | 23 | 27 | ||||
| Total | 25 | 35 | 201 | 231 | 6 |
Highest pathogenic variant AF is 0.00006478371
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CC2D1A | protein_coding | protein_coding | ENST00000318003 | 29 | 24679 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00846 | 0.992 | 124739 | 0 | 66 | 124805 | 0.000264 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.941 | 541 | 606 | 0.892 | 0.0000402 | 6060 |
| Missense in Polyphen | 172 | 199.42 | 0.86249 | 1987 | ||
| Synonymous | 0.212 | 247 | 251 | 0.983 | 0.0000170 | 1983 |
| Loss of Function | 4.99 | 15 | 55.0 | 0.273 | 0.00000286 | 615 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000217 | 0.000216 |
| Ashkenazi Jewish | 0.00192 | 0.00169 |
| East Asian | 0.000446 | 0.000445 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000196 | 0.000194 |
| Middle Eastern | 0.000446 | 0.000445 |
| South Asian | 0.000369 | 0.000360 |
| Other | 0.000508 | 0.000495 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor that binds specifically to the DRE (dual repressor element) and represses HTR1A gene transcription in neuronal cells. The combination of calcium and ATP specifically inactivates the binding with FRE. May play a role in the altered regulation of HTR1A associated with anxiety and major depression. Mediates HDAC-independent repression of HTR1A promoter in neuronal cell. Performs essential function in controlling functional maturation of synapses (By similarity). Plays distinct roles depending on its localization. When cytoplasmic, acts as a scaffold protein in the PI3K/PDK1/AKT pathway. Repressor of HTR1A when nuclear. In the centrosome, regulates spindle pole localization of the cohesin subunit SCC1/RAD21, thereby mediating centriole cohesion during mitosis. {ECO:0000250, ECO:0000269|PubMed:20171170}.;
- Disease
- DISEASE: Mental retardation, autosomal recessive 3 (MRT3) [MIM:608443]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Non-syndromic mental retardation patients do not manifest other clinical signs. {ECO:0000269|PubMed:16033914}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways;EGFR1
(Consensus)
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.719
- rvis_EVS
- 1.45
- rvis_percentile_EVS
- 95.16
Haploinsufficiency Scores
- pHI
- 0.0956
- hipred
- Y
- hipred_score
- 0.547
- ghis
- 0.478
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.972
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cc2d1a
- Phenotype
- growth/size/body region phenotype; cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;positive regulation of I-kappaB kinase/NF-kappaB signaling
- Cellular component
- fibrillar center;nucleus;microtubule organizing center;cytosol;plasma membrane;membrane;extracellular exosome
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;protein binding;cadherin binding